Written question asked by Lord Taylor of Goss Moor (Liberal Democrat) on Tuesday, 27 February 2001, in the House of Commons. It was due for an answer on Monday, 5 March 2001. It was answered by Lord Moonie (Labour) on Monday, 5 March 2001 on behalf of the Ministry of Defence.
Ministry of Defence
- Question
- To ask the Secretary of State for Defence, pursant to his Answer of 25th January 2001 at 361 c659W, regarding oripavine, if he will place in the Libary a list of the technical papers which discuss the different aspects of Porton's research on TL 2636, specifying the title, number and date of each paper. - Includes list of papers.
- Answer
-
Mr. Matthew Taylor: To ask the Secretary of State for Defence pursuant to his answer of 25 January 2001, Official Report, column 659W, regarding Oripavine, if he will place in the Library a list of the technical papers which discuss the different aspects of Porton's research on TL2636, specifying the title, number and date of each paper. [152050] Dr. Moonie: The Chemical and Biological Defence Sector of DERA at Porton Down have identified several internal technical reports which relate to research involving Oripavine TL2636. These are as follows: Porton Technical Paper 0835: Oripavine derivative (TL2636) as a potential incapacitating agent. 1963 Porton Technical Paper 0951: Prediction of biological activity. 1966 Nancekuke Internal Note 9: Some applications of potentiometric titrations in non-aqueous media. 1965 Nancekuke Internal Note 16: Analysis of tertiary alcohols of the 6:14 endetheno tetrahydro Oripavine series. 1966 Nancekuke Report 78: Preparation of tertiary alcohols of the 6:14 endetheno tetrahydro Oripavine series. 1966 Porton Down Technical Paper 939: N-dealkylation of Oripavine derivatives and its significance in their pharmacological activity. Date unknown. Technical Paper 008: Neuropharmacological comparison in the cat of the catalepsy producing drugs morphine and bulbocapnine. 1969 Technical Paper 068: Effects of small doses of an Oripavine derivative on human subjects under both laboratory and field conditions. 1972. The following three reports have some reference to Oripavine TL2636: Annual Summary Report 1965-1966. 1966 CW Applications Discussion Group: 17{th} Quadripartite CBR Conference. 1964 Applied Biology Committee Chemical Defence Establishment: Effects of small doses of TL2636 on human subjects at rest and exercising in the laboratory and the field. 1968. The majority of these reports are over 30-years-old and are part of the Porton Down archive holding of records which have been progressively transferred to the main MOD repository at Hayes. Since 1998, the majority of the above technical reports and other material have been forwarded to MOD archives for review, in accordance with normal procedures, and eventual transfer to the Public Records Office.
Secondary information
- Type
- Written question
- Reference
- 152050; 364 c20W
- Session
- 2000-01
- Subjects
- Armed forces Chemical and biological warfare Chemical weapons Research Voluntary work Chemical Defence Establishment Oripavine
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2022-02-10 16:42:54 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_681345
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_681345
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_681345